First participants have been successfully dosed in a Phase I Clinical Trial of MAP 315, Microba’s lead Therapeutic Program in Inflammatory Bowel Disease. MAP 315, is a novel live biotherapeutic ...

The analysts covering Microba Life Sciences Limited (ASX:MAP) delivered a dose of negativity to shareholders today, by making a substantial revision to their statutory forecasts for this year. Revenue ...

Even if it's not a huge purchase, we think it was good to see that Alexander Waislitz, a Microba Life Sciences Limited (ASX:MAP) insider, recently shelled out AU$126k to buy stock, at AU$0.32 per ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

Australian gut health startup Microba has been using the Google Cloud Platform (GCP) to gain a deeper understanding of customers' gut microbiome. According to Microba, the gut microbiome plays a ...

BRISBANE, Australia--(BUSINESS WIRE)--Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”) is excited to announce it has identified three therapeutic leads for the Company’s ...

Leaders in precision gut microbiome science Microba Life Sciences has united with Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, to advance ...

BRISBANE, Australia--(BUSINESS WIRE)--$MAP--Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”) is an Australian-based commercial stage ...

Experts in gut microbiome analysis, Microba Life Sciences, is empowering global consumer goods company Unilever to take a novel approach to this problem by exploring the links between sleep and the ...

71.4% of MetaXplore™ reports from 4,616 patients identified actionable results 41.9% tested positive for abnormal microbiome markers linked to gastrointestinal health 9.9% tested positive for ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. When you buy individual stocks, you can make higher profits, but you also face the risk of ...